A Clinical Analysis Of229Cases Mucinous Borderline Ovarian Tumors

Objective:The aim of the present study was to discuss the clinicopathological features and prognostic factors associated with mucinous borderline ovarian tumors (MBOTs).Materials and methods:All patients diagnosed with mucinous borderline ovarian tumors and treated between January2000and December2013at Women’s Hospital, School of Medicine, Zhejiang University were reviewed retrospectively. Data was obtained from hospital records. A total of229patients were identified。Results:The median age was31years (range,10-83years).Only75patients(32.8%) accepted comprehensive surgical staging, The majority of the patients (72/75,96.0%) exhibited International Federation of Obstetrics and Gynecology(FIGO) stage I, and the remainder exhibited FIGO stage II/III (1.3%and2.7%,respectively).Agreement between frozen and paraffin sections was131/207(63.3%).Under-diagnosis of frozen section was35.3%(73/207),and over-diagnosis was1.4%(3/207). All patients underwent surgery.160patients received conservative surgery, and4patients exhibited recurrence. Among all patients,76patients underwent lymphadenectomy, but none was found metastasis.Conclusions:MBOTs mainly occur on reproductive age women and are diagnosed in early stage. The prognosis of MBOTs is excellent. Our data suggests that patients with MBOTs who are early-staged、young and eager for preserving their fertility can undergo fertility sparing surgery with close follow-up.